Physician profile
Richard E Roby
NPI 1518073121
$1,666.34
in general payments reported to CMS, 2019-2025
19 companies · $600 in 2025
The $600 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $117 · 2021: $13.89 · 2024: $621 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,220.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $357.66 | 2019-2025 | Evenity, Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $223.44 | 2019-2025 | |
| Novo Nordisk INC | $213.76 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Dexcom, INC. | $130.38 | 2024-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $124.64 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $92.89 | 2024-2025 | Gemtesa, Myfembree |
| Merck Sharp & Dohme LLC | $90.80 | 2019-2025 | Capvaxive |
| Abbvie INC. | $71.85 | 2024-2025 | |
| Exact Sciences Corporation | $64.72 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $55.59 | 2019-2020 | |
| Medtronic, INC. | $50.00 | 2024 | Abre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.94 | 2024-2025 | Jardiance |
| Viatris Specialty LLC | $30.70 | 2025 | Yupelri |
| Abiomed | $26.61 | 2025 | |
| Lilly USA, LLC | $22.52 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $22.36 | 2020 | |
| Abbott Laboratories | $18.70 | 2025 | Freestyle Libre 3 |
| Lundbeck LLC | $16.30 | 2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $14.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Roby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.